Rodziewicz, Mia ;
Dyball, Sarah ;
Lunt, Mark...
Rodziewicz , M , Dyball , S , Lunt , M , McDonald , S , Sutton , E , Parker , B , Bruce , I N , Abernethy , R , Ahmad , Y , Akil , M , Bartram , S , Batley , M , Bharadwaj , A , Bruce , I N , Carlucci , F , Chan , A , Dasgupta , B , D'Cruz , D , Lord , D D , Dyke , B , Edwards , C , Erb , N , Farrell , A , Gayed , M , Gendi , N , Gompels , L , Gordon , C , Gordon , P , Griffiths , B , Gullick , N , Gunwardena , H , Haigh , R , Hamdulay , S , Haque , S , Hutchinson , D , Isenberg , D , Jayne , D , Jeffery , R , Kapur , D , Kaul , A , King , J , Knights , S , Korendowych , E , Lanyon , P , Mahindrakar , M , Marks , J , McCann , L , McLaren , Z , Mediwake , R , Menon , A & Mewar , D 2023 , ' Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study ' , The Lancet Rheumatology , vol. 5 , no. 5 , pp. e284-e292 . https://d....
,
2023
